Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 3, Double-Blind, Placebo-Controlled, Multicenter Clinical Study comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin-Oregovomab) versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) in Patients with Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma(FLORA-5)(QPT-ORE-005/GOG-3035)

  • Details

ClinicalTrials.gov ID: NCT04498117
Diagnosis Type: Peritoneal Cancer
USOR Number: 21253

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 3, Open-Label, Randomized Study of Amivantamab and Lazertinib in Combination with Platinum-Based Chemotherapy Compared with Platinum-Based Chemotherapy in Patients with EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer After Osimertinib Failure (61186372NSC3002)

  • Details

ClinicalTrials.gov ID: NCT04988295
Diagnosis Type: Lung Cancer
USOR Number: 21239

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

A Phase 3, Open-Label, Randomized Study of Amivantamab and Lazertinib in Combination with Platinum-Based Chemotherapy Compared with Platinum-Based Chemotherapy in Patients with EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer After Osimertinib Failure (61186372NSC3002)

  • Details

ClinicalTrials.gov ID: NCT04988295
Diagnosis Type: Lung Cancer
USOR Number: 21239

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 754-1256

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A randomized, double-blind, phase III study comparing NIS793 in combination with gemcitabine and nab-paclitaxel versus placebo combined with gemcitabine and nab-paclitaxel for first line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC) (CNIS793B12301)

  • Details

ClinicalTrials.gov ID: NCT04935359
Diagnosis Type: Pancreatic Cancer
USOR Number: 21235

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

RMC-4630-03: A Phase 2, Open-Label, Multicenter Study of the Combination of RMC-4630 and Sotorasib for Non-Small Cell Lung Cancer Subjects with KRAS G12C Mutation After Failure of Prior Standard Therapies

  • Details

ClinicalTrials.gov ID: NCT05054725
Diagnosis Type: Lung Cancer
USOR Number: 21219

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

RMC-4630-03: A Phase 2, Open-Label, Multicenter Study of the Combination of RMC-4630 and Sotorasib for Non-Small Cell Lung Cancer Subjects with KRAS G12C Mutation After Failure of Prior Standard Therapies

  • Details

ClinicalTrials.gov ID: NCT05054725
Diagnosis Type: Lung Cancer
USOR Number: 21219

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 754-1256

More Details View Practice Page

Breast Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

EMBER-3: A Phase 3, Randomized, Open-Label, Study of Imlunestrant, Investigator’s Choice of Endocrine Therapy, and Imlunestrant plus Abemaciclib in Patients with Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated with Endocrine Therapy (J2J-OX-JZLC)

  • Details

ClinicalTrials.gov ID: NCT04975308
Diagnosis Type: Breast Cancer
USOR Number: 21183

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Breast Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

EMBER-3: A Phase 3, Randomized, Open-Label, Study of Imlunestrant, Investigator’s Choice of Endocrine Therapy, and Imlunestrant plus Abemaciclib in Patients with Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated with Endocrine Therapy (J2J-OX-JZLC)

  • Details

ClinicalTrials.gov ID: NCT04975308
Diagnosis Type: Breast Cancer
USOR Number: 21183

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 754-1256

More Details View Practice Page

Leukemia

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A phase III, multi-center, open-label, randomized study of oral asciminib versus Investigator selected TKI in patients with newly diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (CABL001J12301)

  • Details

ClinicalTrials.gov ID: NCT04971226
Diagnosis Type: Leukemia
USOR Number: 21171

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Randomized, Double-Blind, Placebo-Controlled Trial of Tomivosertib in Combination With Anti-PD-(L)1 Therapy in Subjects With Non-Small Cell Lung Cancer as First-Line Therapy or When Progressing on Single-Agent First-Line Anti-PD-(L)1 Therapy (eFT508-0011)

  • Details

ClinicalTrials.gov ID: NCT04622007
Diagnosis Type: Lung Cancer
USOR Number: 20423

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page